SOX2, a pluripotency-associated transcription factor, is an emerging biomarker for the prediction of prognosis and therapeutic targets for cancer treatment because it plays an important role in the development and maintenance of the stem cell state and is associated with cancer progression [6]. The gene discussed is SOX2; the disease is cancer.